Literature DB >> 16263947

Wheeze, asthma diagnosis and medication use: a national adult survey in a developing country.

R I Ehrlich1, N White, R Norman, R Laubscher, K Steyn, C Lombard, D Bradshaw.   

Abstract

BACKGROUND: As relatively little is known about adult wheeze and asthma in developing countries, this study aimed to determine the predictors of wheeze, asthma diagnosis, and current treatment in a national survey of South African adults.
METHODS: A stratified national probability sample of households was drawn and all adults (>14 years) in the selected households were interviewed. Outcomes of interest were recent wheeze, asthma diagnosis, and current use of asthma medication. Predictors of interest were sex, age, household asset index, education, racial group, urban residence, medical insurance, domestic exposure to smoky fuels, occupational exposure, smoking, body mass index, and past tuberculosis.
RESULTS: A total of 5671 men and 8155 women were studied. Although recent wheeze was reported by 14.4% of men and 17.6% of women and asthma diagnosis by 3.7% of men and 3.8% of women, women were less likely than men to be on current treatment (OR 0.6; 95% confidence interval (CI) 0.5 to 0.8). A history of tuberculosis was an independent predictor of both recent wheeze (OR 3.4; 95% CI 2.5 to 4.7) and asthma diagnosis (OR 2.2; 95% CI 1.5 to 3.2), as was occupational exposure (wheeze: OR 1.8; 95% CI 1.5 to 2.0; asthma diagnosis: OR 1.9; 95% CI 1.4 to 2.4). Smoking was associated with wheeze but not asthma diagnosis. Obesity showed an association with wheeze only in younger women. Both wheeze and asthma diagnosis were more prevalent in those with less education but had no association with the asset index. Independently, having medical insurance was associated with a higher prevalence of diagnosis.
CONCLUSIONS: Some of the findings may be to due to reporting bias and heterogeneity of the categories wheeze and asthma diagnosis, which may overlap with post tuberculous airways obstruction and chronic obstructive pulmonary disease due to smoking and occupational exposures. The results underline the importance of controlling tuberculosis and occupational exposures as well as smoking in reducing chronic respiratory morbidity. Validation of the asthma questionnaire in this setting and research into the pathophysiology of post tuberculous airways obstruction are also needed.

Entities:  

Mesh:

Year:  2005        PMID: 16263947      PMCID: PMC1747242          DOI: 10.1136/thx.2004.030932

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  18 in total

1.  The European Community Respiratory Health Survey: what are the main results so far? European Community Respiratory Health Survey II.

Authors:  C Janson; J Anto; P Burney; S Chinn; R de Marco; J Heinrich; D Jarvis; N Kuenzli; B Leynaert; C Luczynska; F Neukirch; C Svanes; J Sunyer; M Wjst
Journal:  Eur Respir J       Date:  2001-09       Impact factor: 16.671

2.  Physician-diagnosed asthma and drug utilization in the European Community Respiratory Health Survey.

Authors:  C Janson; S Chinn; D Jarvis; P Burney
Journal:  Eur Respir J       Date:  1997-08       Impact factor: 16.671

3.  Validity and repeatability of the IUATLD (1984) Bronchial Symptoms Questionnaire: an international comparison.

Authors:  P G Burney; L A Laitinen; S Perdrizet; H Huckauf; A E Tattersfield; S Chinn; N Poisson; A Heeren; J R Britton; T Jones
Journal:  Eur Respir J       Date:  1989-11       Impact factor: 16.671

4.  Birth weight, body mass index and asthma in young adults.

Authors:  S O Shaheen; J A Sterne; S M Montgomery; H Azima
Journal:  Thorax       Date:  1999-05       Impact factor: 9.139

Review 5.  Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary.

Authors:  R A Pauwels; A S Buist; P M Calverley; C R Jenkins; S S Hurd
Journal:  Am J Respir Crit Care Med       Date:  2001-04       Impact factor: 21.405

6.  Educational level and obstructive lung disease given smoking habits and occupational airborne exposure: a Norwegian community study.

Authors:  P S Bakke; R Hanoa; A Gulsvik
Journal:  Am J Epidemiol       Date:  1995-06-01       Impact factor: 4.897

7.  Prevalence and risk factors for chronic bronchitis in Pelotas, RS, Brazil: a population-based study.

Authors:  A M Menezes; C G Victora; M Rigatto
Journal:  Thorax       Date:  1994-12       Impact factor: 9.139

8.  Chronic pulmonary function impairment caused by initial and recurrent pulmonary tuberculosis following treatment.

Authors:  E Hnizdo; T Singh; G Churchyard
Journal:  Thorax       Date:  2000-01       Impact factor: 9.139

9.  The prevalence of self-reported asthma and respiratory symptoms in Ankara, Turkey.

Authors:  Y Saraçlar; F Cetinkaya; A Tuncer; O Kalayci; G Adalioğlu; B E Sekerel; Y Demirel; Z Misirhgil
Journal:  Respir Med       Date:  1997-09       Impact factor: 3.415

10.  Prevalence of respiratory symptoms, bronchial hyperreactivity, and asthma in a megacity. Results of the European community respiratory health survey in Mumbai (Bombay).

Authors:  R V Chowgule; V M Shetye; J R Parmar; A M Bhosale; M R Khandagale; S V Phalnitkar; P C Gupta
Journal:  Am J Respir Crit Care Med       Date:  1998-08       Impact factor: 21.405

View more
  15 in total

1.  Use of national health interview data to measure the burden of disease and injuries.

Authors:  F J Basterra-Gortari; M Segui-Gomez
Journal:  Inj Prev       Date:  2007-08       Impact factor: 2.399

2.  Asthma and Allergic Disorders in Uganda: A Population-Based Study Across Urban and Rural Settings.

Authors:  Brooks W Morgan; Trishul Siddharthan; Matthew R Grigsby; Suzanne L Pollard; Robert Kalyesubula; Robert A Wise; Bruce Kirenga; William Checkley
Journal:  J Allergy Clin Immunol Pract       Date:  2018-02-01

3.  Clinico-Radiologic and Spirometric Profile of an Indian Population with Post-Tuberculous Obstructive Airway Disease.

Authors:  Avradip Santra; Pravati Dutta; Rekha Manjhi; Sudarsan Pothal
Journal:  J Clin Diagn Res       Date:  2017-03-01

4.  The Jamaica asthma and allergies national prevalence survey: rationale and methods.

Authors:  Eulalia K Kahwa; Novie O Younger; Yvonne B Wint; Norman K Waldron; Hermi H Hewitt; Jennifer M Knight-Madden; Kay A Bailey; Nancy C Edwards; Laurel R Talabere; Karen N Lewis-Bell
Journal:  BMC Med Res Methodol       Date:  2010-04-03       Impact factor: 4.615

5.  An estimate of asthma prevalence in Africa: a systematic analysis.

Authors:  Davies Adeloye; Kit Yee Chan; Igor Rudan; Harry Campbell
Journal:  Croat Med J       Date:  2013-12       Impact factor: 1.351

6.  Prevalence of asthma and allergic rhinitis among adults in Yaounde, Cameroon.

Authors:  Eric Walter Pefura-Yone; André Pascal Kengne; Adamou Dodo Balkissou; Julie Raïcha Boulleys-Nana; Nelly Rachel Efe-de-Melingui; Patricia Ingrid Ndjeutcheu-Moualeu; Charles Lebon Mbele-Onana; Elvira Christelle Kenmegne-Noumsi; Barbara Linda Kolontchang-Yomi; Boris Judicaël Theubo-Kamgang; Emilienne Régine Ebouki; Chrystelle Karen Djuikam-Kamga; Christiane Gaelle Magne-Fotso; Francine Amougou; Liliane Mboumtou; Martine Ngo-Yonga; Elsie Linda Petchou-Talla; Emmanuel Afane-Ze; Christopher Kuaban
Journal:  PLoS One       Date:  2015-04-08       Impact factor: 3.240

Review 7.  Asthma caused by occupational exposures is common - a systematic analysis of estimates of the population-attributable fraction.

Authors:  Kjell Torén; Paul D Blanc
Journal:  BMC Pulm Med       Date:  2009-01-29       Impact factor: 3.317

8.  Chronic diseases of lifestyle risk factor profiles of a South African rural community.

Authors:  Mukadas O Akindele; Ushotanefe Useh
Journal:  J Public Health Afr       Date:  2021-06-18

9.  Socio-epidemiological Aspects of Respiratory Allergic Diseases in Southern Africa.

Authors:  Luís Taborda-Barata; Paul C Potter
Journal:  World Allergy Organ J       Date:  2012-01-13       Impact factor: 4.084

10.  Not all that wheezes is asthma!

Authors:  José Antônio Baddini Martinez
Journal:  J Bras Pneumol       Date:  2013 Jun-Aug       Impact factor: 2.624

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.